4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News
September 3, 2010 11:28 am US/Eastern
Search
Dynamic quotes   
On
 | Off

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI-AVENTIS   SAN   FR0000120578

SANOFI-AVENTIS (SAN)

Real time Streaming quotes -
Real-time Quote. Real-time Tradegate - 09/03 11:28:33 am
46.763 EUR   +0.84%
09/01SANOFI-AVENTIS: Largest Atrial Fibrillation Registry Reveals Poor AF Control an..
08/30SANOFI-AVENTIS: Information concerning the total number of voting rights and sh..
08/30SANOFI-AVENTIS: Teriflunomide Significantly Reduced Annualized Relapse Rate and..
 SummaryQuotesChart AnalysisNewsCalendarCompanyFundamentalsConsensus
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris - 09/03 11:13:34 am
08/30/2010 08/31/2010 09/01/2010 09/02/2010 09/03/2010 Date
45.56(c) 45.27(c) 46.62(c) 46.375(c) 46.62 Last
2 491 467 4 703 065 3 682 353 1 960 318 1 903 109 Volume
+0.66% -0.64% +2.98% -0.53% +0.53% Change
More quotes
Fundamentals (€)
Revenue 2010 30 598 M
EBIT 2010 10 943 M
Net Profit 2010 6 982 M
Debt 2010 732,0 M
Yield 2010 5,45%
Revenue 2011 30 160 M
EBIT 2011 10 671 M
Net Profit 2011 7 046 M
Trésorie 2011 2 876 M
Yield 2011 5,63%
PER 2010 8,89
PER 2011 8,63
VE / Revenue 2010 2,00x
VE / Revenue 2011 1,91x
Capitalization 60 507 M
More Fundamentals
Sector
Pharmaceuticals - Diversified
Calendar

- Aucun évènement disponible -

Business Summary
Sanofi-Aventis is the largest European pharmaceutical group. Net sales per product family break down as follows: - pharmaceutical products (88,1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders...
Read more
Latest news on SANOFI-AVENTIS
09/01SANOFI-AVENTIS: Largest Atrial Fibrillation Registry Reveals Poor AF Control an..
08/30SANOFI-AVENTIS: Information concerning the total number of voting rights and sh..
08/30SANOFI-AVENTIS: Teriflunomide Significantly Reduced Annualized Relapse Rate and..
08/30SANOFI-AVENTIS: Announces Non-Binding Offer to Acquire Genzyme
08/30SANOFI-AVENTIS: Multaq® First-line Option in New 2010 ESC Guidelines for the Ma..
08/26SANOFI-AVENTIS: Comments on Injunctive Relief Hearing Regarding Lovenox®
08/02SANOFI-AVENTIS: Availability on line of the Group's half-year financial report ..
07/29SANOFI-AVENTIS: video Q&A: CEO Chris Viehbacher comments on earnings for Q2 201..
07/27SANOFI-AVENTIS: and Merck appoint Raul Kohan as CEO for the new Animal Health j..
07/26SANOFI-AVENTIS: expresses concern over the approval of another version of enoxa..
07/23SANOFI-AVENTIS: Information concerning the total number of voting rights and sh..
07/19SANOFI-AVENTIS: Jevtana® (cabazitaxel) Injection Now Available in the U.S.
More news
Chart SANOFI-AVENTIS
Mid-term
Graphique historique des cours de bourse de SANOFI-AVENTIS
Full-screen chart
Trends chart analysis
Short termMid-termLong term
NeutralBearishNeutral
Chart Analysis
Income Statement Evolution
SANOFI-AVENTIS : Income Statement Evolution
More Fundamentals
EPS Reviews
SANOFI-AVENTIS : EPS Reviews
More Estimates Reviews
Price share SANOFI-AVENTIS (FRANCE), Source for Financial Market Quotes, Charts, Technical Analysis and Consensus. Stock market quotes including the latest stock price , stock market quote for the NASDAQ 100, news and fundamental investing data and price charts. The easy way to get information on stocks, currencies, indexes, commodities , certicates, and Warrants. Contact us ¤ Site map
Quotes are delayed 15 minutes for Nasdaq, Nyse and Euronext. Dow Jones indexes from Dow Jones & Company and Nasdaq indexes are 15 minutes delayed. CAC 40, Forex and Tradegate exchange are in real-time. Others exchanges are in end of day. Data are provided by Interactive Data - Tijd Beursmedia.
Copyright ©  2001 - 2010 Surperformance SAS /